Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition

Endocrine Practice

Volumn 20, Issue 1, 2014, Pages 41-45

  Farrokhi, Farnoosh ^a   Chandra, Prakash ^a   Smiley, Dawn ^a   Pasquel, Francisco ^a   Peng, Limin ^b   Newton, Christopher ^a   Umpierrez, Guillermo ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; APACHE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL PATIENT; TEACHING HOSPITAL; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; ADVERSE EFFECTS; AGED; ANALYSIS; HOSPITAL MORTALITY;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES;

EID: 84892741831     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13131.OR     Document Type: Article

References (29)

1. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
2. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
3. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
4. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78: 1471-1478.
5. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-Analysis including NICE-SUGAR study data. CMAJ. 2009;180:821-827.
6. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
7. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med. 2010;38:1021-1029.
8. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH. Glucose variability; does it matter? Endocr Rev. 2010;31: 171-182.
9. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
10. Giner M, Laviano A, Meguid MM, Gleason Jr. In 1995 a correlation between malnutrition and poor outcome in critically ill patients still exists. Nutrition. 1996;12:23-29.
11. Kumar PR, Crotty P, Raman M. Hyperglycemia in hospitalized patients receiving parenteral nutrition is associated with increased morbidity and mortality: a review. Gastroenterol Res Pract. 2011;2011:pii: 760720.
12. Heyland DK, Montalvo M, MacDonald S, Keefe L, Su XY, Drover JW. Total parenteral nutrition in the surgical patient: a meta-Analysis. Can J Surg. 2001;44:102-111.
13. Ziegler TR. Parenteral nutrition in the critically ill patient. N Engl J Med. 2009;361:1088-1097.
14. der Voort PH, Feenstra RA, Bakker AJ, Heide L, Boerma EC, van der Horst IC. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf). 2006;64:141-145.
15. Pasquel FJ, Spiegelman R, McCauley M, et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33:739-741.
16. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006; 105:244-252.
17. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008-3013.
18. Ali NA, O'Brien JM Jr, Dungan K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36:2316-2321.
19. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med. 2009;169:438-446.
20. Lipska KJ, Venkitachalam L, Gosch K, et al. Glucose variability and mortality in patients hospitalized with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012;5:550-557.
21. Pidcoke HF, Wanek SM, Rohleder LS, Holcomb JB, Wolf SE, Wade CE. Glucose variability is associated with high mortality after severe burn. J Trauma. 2009;67:990-995.
22. Egi M, Finfer S, Bellomo R. Glycemic control in the ICU. Chest. 2011;140:212-220.
23. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795-2804.
24. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001;281:E924-E930.
25. Azuma K, Kawamori R, Toyofuku Y, et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol. 2006;26:2275-2280.
26. Watada H, Azuma K, Kawamori R. Glucose fluctuation on the progression of diabetic macroangiopathy-new findings from monocyte adhesion to endothelial cells. Diabetes Res Clin Pract. 2007;77:S58-61.
27. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-1687.
28. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27:1289-1297.
29. Schisano B, Tripathi G, McGee K, McTernan PG, Ceriello A. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011;54:1219-1226.